ADJUVANT TREATMENT OF GASTRIC CANCER

ADJUVANT TREATMENT OF GASTRIC CANCER

The article analyzes the results of a randomized multicenter studies devoted to elucidate the role of adjuvant and neoadjuvant chemotherapy, targeted therapy, adjuvant chemoradiation therapy in improving the results of surgical treatment of gastric cancer.

Saved in:

Bibliographic Details
Main Authors:	D. T. Arybzhanov, I. R. Rakhmatullina
Format:	Article
Language:	English
Published:	Bashkir State Medical University 2017-02-01
Series:	Креативная хирургия и онкология
Subjects:	gastric cancer treatment adjuvant chemotherapy targeted therapy chemoradiation therapy
Online Access:	https://www.surgonco.ru/jour/article/view/197
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Beyond GOG258 and PORTEC3: A National Cancer Database analysis of adjuvant therapy for improved survival in high-risk endometrial cancer
by: Megan E Lander, et al.
Published: (2025-06-01)

Impact of adjuvant chemotherapy on relapse-free survival of patients with locally advanced cervical cancer
by: M. P. Smirnova, et al.
Published: (2022-01-01)

SURGICAL TREATMENT OF REGIONAL RECURRENCE FROM GASTRIC CANCER AFTER MULTIMODAL TREATMENT WITH NEOADJUVANT CHEMORADIOTHERAPY (A CASE REPORT)
by: V. Yu. Skoropad, et al.
Published: (2018-05-01)

Adjuvant chemotherapy for gastric cancer
by: I. P. Kolesnyk, et al.
Published: (2015-12-01)

Toxicity profile of double-agent adjuvant chemotherapy after concurrent chemoradiation and brachytherapy in locally advanced cervical cancer: Comparison with standard chemoradiation protocol
by: Tejas Pandya, et al.
Published: (2019-01-01)

Evaluating the benefit of adjuvant radiotherapy after extensive lymph node dissection for gastric cancer: a single-institute retrospective study
by: Yu-Nong Wang, et al.
Published: (2021-01-01)

The impact of delayed adjuvant chemotherapy on survival in gastric cancer patients with and without preoperative chemotherapy
by: Masataka Shimonosono, et al.
Published: (2025-07-01)

Expediency of radiation therapy and adjuvant polychemotherapy in surgical treatment of cancer
by: Khvorostenko M.I., et al.
Published: (2016-05-01)

Prognostic factors and adjuvant chemotherapy efficacy in stage I gastric cancer patients: a retrospective analysis
by: Hua Xiao, et al.
Published: (2024-12-01)

Evolution of drug therapy in patients with resectable gastric and esophageal‑gastric junction cancer
by: M. V. Sedova, et al.
Published: (2023-06-01)

Adjuvant chemotherapy may have no significant survival benefit in older patients with stage II/III gastric cancer: a multicenter retrospective study
by: Zheng-Zheng Shen, et al.
Published: (2025-05-01)

Report from the 26th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Hepatocellular and Biliary Tract Cancer, Saskatoon, Saskatchewan, 17–18 October 2024
by: Deepti Ravi, et al.
Published: (2025-07-01)

Comparison of PSOX (paclitaxel, oxaliplatin, S-1) and SOX (oxaliplatin, S-1) as postoperative adjuvant chemotherapy for stage II-III gastric cancer
by: Fei-Yu Wang, et al.
Published: (2025-03-01)

A prospective randomized comparison of concurrent chemoradiation with neoadjuvant and adjuvant chemotherapy with concurrent chemoradiation alone for locally advanced carcinoma cervix
by: Rahul Singh, et al.
Published: (2019-01-01)

OUR EXPERIENCE OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PATIENTS WITH ADVANCED GASTRIC CANCER
by: A. D. Kaprin, et al.
Published: (2016-01-01)

EFFICACY OF TARGET THERAPY WITH CRIZOTINIB IN A PATIENT WITH ALK-POSITIVE ADVANCED GASTRIC CANCER
by: A. A. Paichadze, et al.
Published: (2020-03-01)

Adjuvant chemotherapy for stage II and III gastric adenocarcinoma: A retrospective analysis with long-term follow-up
by: Hsiu-Tzu Wang, et al.
Published: (2025-04-01)

Neoadjuvant treatment of esophageal cancer: chemotherapy, chemoradiation, immunotherapy, and future trends of therapy
by: Malekzada Freschta, et al.
Published: (2024-11-01)

PATHOLOGICAL RESPONSE OF GASTRIC CANCER TO NEOADJUVANT PROLONGED CHEMORADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY
by: Е. F. Lushnikov, et al.
Published: (2016-02-01)

Prognostic Significance of Delays in Initiation of Adjuvant Trastuzumab-Based Therapy in Patients with HER2-Positive Breast Cancer
by: Gavin P. Dowling, et al.
Published: (2025-05-01)

Survival benefits of postoperative adjuvant chemotherapy in adults aged ≥ 80 years with locally advanced gastric cancer: insights from a population-based study
by: Fuhai Ma, et al.
Published: (2025-05-01)

EFFICACY OF HYPOFRACTIONATED ADJUVANT RADIATION THERAPY IN PATIENTS WITH OPERABLE BREAST CANCER
by: G. V. Afonin, et al.
Published: (2018-11-01)

Timing of postoperative chemotherapy and prognosis in neoadjuvant-treated gastric cancer patients: a multicenter real-world cohort study
by: Hua-Long Zheng, et al.
Published: (2025-12-01)

LONG-TERM OUTCOMES IN BREAST CANCER PATIENTS AFTER COMPLEX TREATMENT WITH ADJUVANT RADIATION THERAPY
by: K. A. Simonov, et al.
Published: (2016-02-01)

Feasibility and predictive factors on the completion of docetaxel plus S‐1 adjuvant chemotherapy in pathological stage III gastric cancer
by: Masayoshi Terayama, et al.
Published: (2025-01-01)

RADIATION TREATMENT OF UNRESECTABLE LARYNGEAL CANCER
by: K. B. Gordon, et al.
Published: (2016-07-01)

INTRA-ATERIAL CHEMOTHERAPY OF THE BREAST CANCER
by: Shamil Kh. Gantsev, et al.
Published: (2017-09-01)

OPTIMIZATION OF THE CHOICE OF ADJUVANT THERAPY IN PATIENTS WITH UTERINE CORPUS CANCER
by: А. L. Chernyshova, et al.
Published: (2016-02-01)

Efficacy and Safety of a 3‐Weekly TS‐1 Adjuvant Regimen in Advanced Gastric Cancer: A Pilot Study
by: Jihong Bae, et al.
Published: (2025-08-01)

Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives
by: Dong Luo, et al.
Published: (2025-02-01)

THE ROLE OF ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED GASTRIC CANCER
by: A. A. Bobryshev, et al.
Published: (2021-03-01)

Intensifying adjuvant therapy in intermediate-risk head and neck cancer: navigating the gray zone, selecting the right patient
by: Samarpita Mohanty, et al.
Published: (2025-05-01)

Peripheral T Lymphocyte Predicts the Prognosis of Gastric Cancer Patients Undergoing Radical Gastrectomy: A Multicenter Retrospective Cohort Study
by: Xiao H, et al.
Published: (2024-12-01)

PHASE 2 MULTICENTER RANDOMIZED CLINICAL TRIAL: NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2020-03-01)

Time to adjuvant chemotherapy and overall survival in advanced-stage ovarian cancer patients in England: a population-based retrospective cohort study
by: L. Steventon, et al.
Published: (2025-06-01)

PLANNING PHASE 2 MULTICENTER RANDOMIZED TRIAL OF NEOADJUVANT CHEMO-RADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2016-07-01)

Results of conservative treatment of locally advanced larynx squamous cell carcinoma using intraarterial regional polychemotherapy
by: D. A. Safarov, et al.
Published: (2021-04-01)

Practical management of oligometastatic gastric cancer
by: Y. Narita, et al.
Published: (2024-12-01)

German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus—version 4.0
by: M.P. Ebert, et al.
Published: (2025-03-01)

Case report of concurrent ulcerative colitis and bilateral breast cancer: a literature review of the bidirectional association between autoimmune diseases and breast cancer
by: Xiao Qi, et al.
Published: (2025-06-01)